About
Male
Matthew Ronsheim is the current COO of Xenon Pharmaceuticals. He previously worked at Innoviva Specialty Therapeutics as a President. Matthew Ronsheim attended the University of New Hampshire.
Experience
IPO385Burnaby, British Columbia, CanadaBiotech/Pharma · Biopharma
- President · Innoviva Specialty Therapeutics2024 – present
Education
- University of New Hampshire · Ph.D., Chemistry1998 – 2002
People at Xenon Pharmaceuticals
Data from: crunchbase
